Verrica Pharmaceuticals Inc (VRCA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.47
• Market Cap: $89.06M
• EPS: $-2.87
• 52-Week High: $9.82
• 52-Week Low: $3.28

Market Sentiment

Verrica Pharmaceuticals Inc currently has a Bullish sentiment score of 0.28.

About Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc. is a specialized dermatological therapy company focused on the development and commercialization of innovative treatments for various skin conditions. Based in West Chester, Pennsylvania, Verrica aims to address significant unmet medical needs through its proprietary formulations and advanced delivery systems. The company is committed to improving patient outcomes by leveraging its expertise in dermatology to provide effective solutions for conditions such as comm...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Verrica Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VRCA pay dividends?

Verrica Pharmaceuticals Inc (VRCA) does not currently pay a regular dividend.

What is VRCA's market cap?

Verrica Pharmaceuticals Inc (VRCA) has a market capitalization of $89.06M with a current stock price of $5.47.